MedPath

Effect of Panchakarma (Vamana) and Varadi Ghanavati in Prameha (Diabetes mellitus)

Phase 2
Completed
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2017/10/010127
Lead Sponsor
The Dean R A Podar Medical College Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
49
Inclusion Criteria

1.Patients showing classical symptoms of Prameha, who are either a known diabetic for less than a year or a newly diagnosed diabetic.

2. Fasting blood sugar below 250 mg/dl and post prandial blood sugar below 500 mg/dl.

3. Fit for Vamana treatment

Exclusion Criteria

1. Fasting blood sugar above 250 mg% and post prandial blood sugar above 500mg%.

2. IDDM and those who are under insulin therapy.

3. Acute or chronic complications of Diabetes mellitus

4. Suffering from other diseases such as Tuberculosis, cardiac diseases.

5. Unfit for Vamana

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effect on symptoms of Prameha according to four point scale at the interval of 2 weeks till 12 weeks. <br/ ><br>Effect on Blood sugar - fasting and post prandial at the interval of 2 weeks till 12 weeks. Effect on glycosylated haemoglobin (HbA1c) at base line and 12 weeks.Timepoint: Effect on symptoms of Prameha according to four point scale. <br/ ><br>Effect on Blood sugar - fasting and post prandial, glycosylated haemoglobin
Secondary Outcome Measures
NameTimeMethod
Effect on lipid profile, Haemogram, Renal profile, Hepatic Profile at the base line and at 12 weeks. Effect on weight and body mass index (BMI) at the interval of 2 weeks till 12 weeksTimepoint: At base line and 12 weeks. <br/ ><br>At the interval of 2 weeks till 12 weeks.
© Copyright 2025. All Rights Reserved by MedPath